uPAR as anti-cancer target: evaluation of biomarker potential, histological localization, and antibody-based therapy

Medicin og biovidenskab

• Antibodies 48%
• Biomarkers 57%
• Extracellular Matrix Proteins 10%
• Fibrinolysis 10%
• Ligands 6%
• Liver 5%
• Monoclonal Antibodies 7%
• Neoplasm Metastasis 6%
• Neoplasms 28%
• Plasminogen Activators 92%
• Proteolysis 27%
• Stromal Cells 9%
• Therapeutics 14%
• Urokinase-Type Plasminogen Activator 100%
• Wound Healing 8%

Kemiske forbindelser

• Biological Marker 79%
• Ligand 12%
• Marker 51%
• Protein 12%
• Protein Hydrolysis 95%
• Surface 18%